Final answer:
Ruth Faden identified two key issues in the Henrietta Lacks case: the question of consent and the moral or legal rights to compensation when something of commercial value is developed. The first issue relates to the absence of informed consent at the time Lacks's tissues were obtained, while the second issue pertains to the use of her cells to develop a commercially valuable cell line.
Step-by-step explanation:
Ruth Faden, a bioethicist, identified two key issues in the Henrietta Lacks case. The first issue she mentioned is the "question of consent." This refers to the fact that when Lacks's tissues were obtained, there were no laws or guidelines regarding informed consent. Today, it is considered both unethical and illegal to harvest tissue without proper consent. However, since there were no regulations at the time, it raises ethical questions about whether Lacks was treated fairly.
The second issue identified by Faden is whether anything is morally or legally due to a person if something of commercial value is developed. In this case, Lacks's cells were used to develop the HeLa cell line, which has been instrumental in numerous scientific breakthroughs and has generated significant commercial value. This raises questions about the rights and compensation that should be afforded to the individual or their descendants when their cells contribute to such advancements.